» Articles » PMID: 18776126

Toll-like Receptor 9 Affects Severity of IgA Nephropathy

Overview
Specialty Nephrology
Date 2008 Sep 9
PMID 18776126
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Environmental pathogens are suspected to aggravate renal injury in IgA nephropathy (IgAN), but neither underlying mechanisms nor specific exogenous antigens have been identified. In this study, a genome-wide scan of ddY mice, which spontaneously develop IgAN, was performed, and myeloid differentiation factor 88 (MyD88) was identified as a candidate gene for progression of renal injury (chi(2) = 21.103, P = 0.00017). For evaluation of the potential influence of environmental pathogens on progression of renal injury, ddY mice were housed in either conventional or specific pathogen-free conditions. Expression of genes encoding toll-like receptors (TLR) and the signaling molecule MyD88 were quantified by real-time reverse transcription-PCR in splenocytes. Although the housing conditions did not affect the prevalence of IgAN, the severity of renal injuries was higher in the conventionally housed group. Mice that had IgAN and were housed in conventional conditions had higher levels of TLR9 and MyD88 transcripts than mice that had IgAN and were housed in specific pathogen-free conditions. Furthermore, nasal challenge with CpG-oligodeoxynucleotides, which are ligands for TLR9, aggravated renal injury, led to strong Th1 polarization, and increased serum and mesangial IgA. For investigation of whether these results may be generalizable to humans, single-nucleotide polymorphisms in the TLR9 and MyD88 genes were analyzed in two cohorts of patients with IgAN; an association was observed between TLR9 polymorphisms and disease progression. In summary, these findings suggest that activation of the TLR9/MyD88 pathway by common antigens may affect the severity of IgAN.

Citing Articles

Lessons from IgA Nephropathy Models.

Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M Int J Mol Sci. 2024; 25(21).

PMID: 39519036 PMC: 11546737. DOI: 10.3390/ijms252111484.


IgA Nephropathy: Emerging Mechanisms of Disease.

Roberts L, Williams C, Oni L, Barratt J, Selvaskandan H Indian J Nephrol. 2024; 34(4):297-309.

PMID: 39156850 PMC: 11326799. DOI: 10.25259/ijn_425_23.


IgA Nephropathy: Significance of IgA1-Containing Immune Complexes in Clinical Settings.

Suzuki H, Novak J J Clin Med. 2024; 13(15).

PMID: 39124764 PMC: 11313413. DOI: 10.3390/jcm13154495.


Accelerated involution of germinal center in palatine tonsils in IgA nephropathy.

Ueda H, Joh K, Ueda Y, Marumoto H, Okabe M, Isaka N PLoS One. 2024; 19(5):e0301853.

PMID: 38709804 PMC: 11073668. DOI: 10.1371/journal.pone.0301853.


Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection.

Song J, Ke B, Tu W, Fang X Ren Fail. 2023; 45(2):2259228.

PMID: 37755331 PMC: 10538460. DOI: 10.1080/0886022X.2023.2259228.


References
1.
Narita I, Saito N, Goto S, Jin S, Omori K, Sakatsume M . Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. Kidney Int. 2002; 61(5):1853-8. DOI: 10.1046/j.1523-1755.2002.00336.x. View

2.
Akira S, Takeda K, Kaisho T . Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001; 2(8):675-80. DOI: 10.1038/90609. View

3.
Janeway Jr C, Medzhitov R . Innate immune recognition. Annu Rev Immunol. 2002; 20:197-216. DOI: 10.1146/annurev.immunol.20.083001.084359. View

4.
Schena F . Immunogenetic aspects of primary IgA nephropathy. Kidney Int. 1995; 48(6):1998-2013. DOI: 10.1038/ki.1995.503. View

5.
Lazarus R, Klimecki W, Raby B, Vercelli D, Palmer L, Kwiatkowski D . Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics. 2003; 81(1):85-91. DOI: 10.1016/s0888-7543(02)00022-8. View